These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31737616)

  • 1. Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model.
    Mendes-Pinheiro B; Anjo SI; Manadas B; Da Silva JD; Marote A; Behie LA; Teixeira FG; Salgado AJ
    Front Bioeng Biotechnol; 2019; 7():294. PubMed ID: 31737616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
    Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ
    Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.
    Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ
    Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.
    Xiong N; Yang H; Liu L; Xiong J; Zhang Z; Zhang X; Jia M; Huang J; Zhang Z; Mohamed AA; Lin Z; Wang T
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):411-422. PubMed ID: 23770451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
    Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
    Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
    Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D
    Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Parkinson's Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration.
    Mendes-Pinheiro B; Campos J; Marote A; Soares-Cunha C; Nickels SL; Monzel AS; Cibrão JR; Loureiro-Campos E; Serra SC; Barata-Antunes S; Duarte-Silva S; Pinto L; Schwamborn JC; Salgado AJ
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
    Cerri S; Greco R; Levandis G; Ghezzi C; Mangione AS; Fuzzati-Armentero MT; Bonizzi A; Avanzini MA; Maccario R; Blandini F
    Stem Cells Transl Med; 2015 Sep; 4(9):1073-85. PubMed ID: 26198165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of bone marrow-derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease.
    Mahendru D; Jain A; Bansal S; Malik D; Dhir N; Sharma AR; Sarma P; Prakash A; Nahar U; Bhatia A; Bhattacharyya S; Medhi B
    Regen Med; 2021 Oct; 16(10):915-930. PubMed ID: 34553608
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurodifferentiation and Neuroprotection Potential of Mesenchymal Stromal Cell-Derived Secretome Produced in Different Dynamic Systems.
    Marques CR; Fuzeta MA; Dos Santos Cunha RM; Pereira-Sousa J; Silva D; Campos J; Teixeira-Castro A; Sousa RA; Fernandes-Platzgummer A; da Silva CL; Salgado AJ
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionating stem cells secretome for Parkinson's disease modeling: Is it the whole better than the sum of its parts?
    Vilaça-Faria H; Marote A; Lages I; Ribeiro C; Mendes-Pinheiro B; Domingues AV; Campos J; Lanceros-Mendez S; Salgado AJ; Teixeira FG
    Biochimie; 2021 Oct; 189():87-98. PubMed ID: 34182001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model.
    Ni W; Zhou J; Ling Y; Lu X; Niu D; Zeng Y; Qiu Y; Si Y; Wang J; Zhang W; Wang Z; Hu J
    Brain Res; 2022 Sep; 1790():147978. PubMed ID: 35690143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson's disease.
    Wang X; Zhuang W; Fu W; Wang X; Lv E; Li F; Zhou S; Rausch WD; Wang X
    Am J Transl Res; 2018; 10(6):1583-1599. PubMed ID: 30018702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
    Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
    J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of TO901317 on GF to promote the differentiation of human bone marrow mesenchymal stem cells into dopamine neurons on Parkinson's disease.
    Li M; Yang J; Cheng O; Peng Z; Luo Y; Ran D; Yang Y; Xiang P; Huang H; Tan X; Wang H
    Ther Adv Chronic Dis; 2021; 12():2040622321998139. PubMed ID: 33796244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.